id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-307201-keec6fzo	Barberio, Brigida	Should IBD Patients Be Tested for Active COVID-19 Prior Starting a Biological Treatment?	2020-08-30		.txt	text/plain	655	43	44	title: Should IBD Patients Be Tested for Active COVID-19 Prior Starting a Biological Treatment? aimed to provide recommendations regarding the management of patients with inflammatory bowel disease (IBD) in the era of COVID-19 pandemic. The AGA suggests that IBD patients should not stop their current treatments in order to prevent infection or adverse outcome with COVID-19. However, there was no specific international guidance with respect to COVID-19 testing in patients starting immunosuppressive treatment, particularly if they are asymptomatic, and the article by Rubin et al did not cover this topic either. 6 Overall, we believe that screening for active COVID-19 infection should be performed in order to avoid potential complications and to adjust therapy accordingly prior starting biological treatment. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak Are patients with inflammatory bowel disease at increased risk for COVID-19 infection ?	./cache/cord-307201-keec6fzo.txt	./txt/cord-307201-keec6fzo.txt